Skip to main content

Table 3 Baseline characteristics of subjects diagnosed with early HMS (e-HMS), with follow-up: treated versus untreated

From: Early hyperreactive malarial splenomegaly and risk factors for evolution into the full-blown syndrome: a single-centre, retrospective, longitudinal study

Characteristic

All (n = 81)a

Treated (n = 56)

Not treated (n = 24)

p value

Age, years [median (IQ range)]

53.4 (38.9–60.9)

54.0 (36.09–60.9)

49.8 (42.5–58.2)

0.502

Gender (F/M)

31/50

22/34

9/15

0.881

Ethnicity (Caucasian/other)

62/19

42/14

19/5

0.688

Exposure, years [median (IQ range)]

20.0 (12.5–28.5)

20.0 (13.0–28.5)

19.0 (13.0–31.5)

0.677

Presence of symptoms, Y/N

74/6

54/2

20/4

0.063

Spleen diameter, cm [median (IQ range)]

14.0 (13.0–15. 0)

14.0 (13.3–15. 0)

14.4 (13.0–15.0)

0.601

Presence of hepatomegaly, Y/N

30/50

20/36

10/14

0.614

Hb, mg/dL [median (IQ range)]

12.3 (11.0–13.3)

12.3 (10.7–13.3)

12.4 (11.9–13.9)

0.154

RBC × 106/µL [median (IQ range)]

4.1 (3.7–4.7)

4.1 (3.7–4.6)

4.4 (4.0–4.7)

0.227

Plt × 103/µL [median (IQ range)]

170.0 (137.0–217.0)

158.0 (129.0–208.0)

201.0 (165.5–250.0)

0.014

ESR, mm/h [median (IQ range)]

25.0 (14.0–47.0)

26.5 (14.5–42.0)

23.0 (16.5–41.5)

0.319

IgM, g/L [median (IQ range)]

2.9 (1.9–3.8)

2.9 (1.7–4.3)

2.8 (2.1–4.1)

0.693

Plasmodium in blood, Y/N

26/33

26/26

7/0

0.014

  1. aInfo on treatment missing in one case